Literature DB >> 6270015

Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells.

J E Shindelman, A E Ortmeyer, H H Sussman.   

Abstract

A transferrin receptor was demonstrated in tumor tissue from 10 patients with breast carcinoma and one patient with breast sarcoma. Binding studies were conducted by measuring the amont of 1251-transferrin binding to microsomal preparations of the tumor tissue. Elevated levels of specific transferrin binding were found in the tumors with a range of 11-35% of bound transferrin, whereas microsomes prepared from non-neoplastic breast tissue samples bound only 2.3% and 2.4% of the transferrin. Scatchard analysis of binding studies conducted with tissues from a breast cancer and from a breast sarcoma indicate that the receptor has a Ka = 9.0 x 10(8)M. The binding site is specific for transferrin, as studies show that non-radioactive transferrin displaced labelled transferrin, while human IgG and human albumin did not. The receptor-transferrin complex was precipitated from a detergent extract of the breast sarcoma with antiserum to human transferrin. Sodium dodecyl sulfate/polyacrylamide gel electrophoresis of the immunoprecipitate gave a polypeptide of M 90,000 daltons, which is of similar molecular weight found for the putative transferrin receptor in all of a series of human cultured cell lines previously examined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270015     DOI: 10.1002/ijc.2910270311

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  40 in total

1.  An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.

Authors:  Patrick P Ng; Jay S Dela Cruz; David N Sorour; James M Stinebaugh; Seung-Uon Shin; Daniel S Shin; Sherie L Morrison; Manuel L Penichet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

Review 2.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

3.  Automated selection of regions of interest for intensity-based FRET analysis of transferrin endocytic trafficking in normal vs. cancer cells.

Authors:  Ronak Talati; Andrew Vanderpoel; Amina Eladdadi; Kate Anderson; Ken Abe; Margarida Barroso
Journal:  Methods       Date:  2013-08-28       Impact factor: 3.608

4.  Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium.

Authors:  Sneha Sundaram; Shyamal K Roy; Balamurali K Ambati; Uday B Kompella
Journal:  FASEB J       Date:  2009-07-16       Impact factor: 5.191

5.  Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.

Authors:  Brian M Barth; Rahul Sharma; Erhan I Altinoğlu; Thomas T Morgan; Sriram S Shanmugavelandy; James M Kaiser; Christopher McGovern; Gail L Matters; Jill P Smith; Mark Kester; James H Adair
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

Review 6.  Convection-Enhanced Delivery.

Authors:  A M Mehta; A M Sonabend; J N Bruce
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

7.  A monoclonal antibody D51 recognizes the transferrin-receptor structure.

Authors:  H J Gross
Journal:  Blut       Date:  1985-08

Review 8.  Transferrin receptor: its biological significance.

Authors:  W S May; P Cuatrecasas
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

9.  Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.

Authors:  R Rossiello; M V Carriero; G G Giordano
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

10.  Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels.

Authors:  M Cotten; F Längle-Rouault; H Kirlappos; E Wagner; K Mechtler; M Zenke; H Beug; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.